These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8114848)

  • 1. Clinical implications of the p53 tumor-suppressor gene.
    Rutz HP; Mirimanoff RO
    N Engl J Med; 1994 Mar; 330(12):864-5. PubMed ID: 8114848
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical implications of the p53 tumor-suppressor gene.
    Harris CC; Hollstein M
    N Engl J Med; 1993 Oct; 329(18):1318-27. PubMed ID: 8413413
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical implications of the p53 tumor-suppressor gene.
    Bokemeyer C; Kuczyk MA; Sehrt J
    N Engl J Med; 1994 Mar; 330(12):865. PubMed ID: 8114849
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical implications of the p53 tumor-suppressor gene.
    Müller M; Volkmann M; Zentgraf H; Galle PR
    N Engl J Med; 1994 Mar; 330(12):865. PubMed ID: 8166834
    [No Abstract]   [Full Text] [Related]  

  • 5. Deletions and insertions in the p53 tumor suppressor gene in human cancers: confirmation of the DNA polymerase slippage/misalignment model.
    Greenblatt MS; Grollman AP; Harris CC
    Cancer Res; 1996 May; 56(9):2130-6. PubMed ID: 8616861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53: balancing tumour suppression and implications for the clinic.
    Buganim Y; Rotter V
    Eur J Cancer; 2009 Sep; 45 Suppl 1():217-34. PubMed ID: 19775621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The multiple tumor suppressor genes in human esophageal cancer].
    Li HC; Lu SX
    Zhonghua Yi Xue Za Zhi; 1994 Aug; 74(8):489-91, 519. PubMed ID: 7994660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [p53 as a molecular target for cancer therapy].
    Ishioka C; Osada M; Gamo M; Kanamaru R
    Gan To Kagaku Ryoho; 1997 Dec; 24(15):2207-12. PubMed ID: 9422063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-associated loss of heterozygosity of tumor suppressor genes in the gastric mucosa of humans.
    Moragoda L; Jaszewski R; Kulkarni P; Majumdar AP
    Am J Physiol Gastrointest Liver Physiol; 2002 Jun; 282(6):G932-6. PubMed ID: 12016117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 mutations: gains or losses?
    Michalovitz D; Halevy O; Oren M
    J Cell Biochem; 1991 Jan; 45(1):22-9. PubMed ID: 2005181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 downstream target genes and tumor suppression: a classical view in evolution.
    Rozan LM; El-Deiry WS
    Cell Death Differ; 2007 Jan; 14(1):3-9. PubMed ID: 17068503
    [No Abstract]   [Full Text] [Related]  

  • 12. Mutation scanning of the p53 tumor suppressor gene in renal and liver transplant patients in Hungary.
    Sarvary E; Nagy P; Benjamin A; Szoke M; Remport A; Jansen J; Nemes B; Kobori L; Fehervari I; Sulyok B; Perner F; Varga M; Fazakas J; Lakatos M; Szabo M; Toth A; Járay J
    Transplant Proc; 2005 Mar; 37(2):969-72. PubMed ID: 15848594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenomatous polyposis coli gene mutation and decreased wild-type p53 protein expression in oral submucous fibrosis: a preliminary investigation.
    Liao PH; Lee TL; Yang LC; Yang SH; Chen SL; Chou MY
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):202-7. PubMed ID: 11505268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53--master and commander.
    Foulkes WD
    N Engl J Med; 2007 Dec; 357(25):2539-41. PubMed ID: 18094374
    [No Abstract]   [Full Text] [Related]  

  • 15. p53 as a potential target in cancer therapy.
    Ozturk M; Ponchel F; Puisieux A
    Bone Marrow Transplant; 1992; 9 Suppl 1():164-70. PubMed ID: 1504661
    [No Abstract]   [Full Text] [Related]  

  • 16. [Tumor suppressor gene p53--function and significance in gastroenterology].
    Schoppmeyer K; Keim V; Mössner J
    Z Gastroenterol; 1997 Jun; 35(6):491-509. PubMed ID: 9281241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The humoral response to the tumor-suppressor gene-product p53 in human cancer: implications for diagnosis and therapy.
    Soussi T
    Immunol Today; 1996 Aug; 17(8):354-6. PubMed ID: 8783493
    [No Abstract]   [Full Text] [Related]  

  • 18. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Semiautomated quantitative detection of loss of heterozygosity in the tumor suppressor gene p53.
    Hahn M; Matzen SE; Serth J; Pingoud A
    Biotechniques; 1995 Jun; 18(6):1040-7. PubMed ID: 7546705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [P53 and cancers].
    May P; May E
    Pathol Biol (Paris); 1995 Mar; 43(3):165-73. PubMed ID: 7675543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.